Victhom appoints Mr. Nader Kameli as Chief Operating Officer of its neuromodulation business unit

    QUEBEC, April 17 /CNW Telbec/ - Victhom Human Bionics Inc. ("Victhom")
(TSX: VHB) announces that Mr. Nader Kameli is joining the Company today as
Chief Operating Officer of the Neurobionix business unit of Victhom which is
responsible for the development and commercialization of its neuromodulation
    "We are very pleased to welcome Mr. Nader Kameli to Victhom. With
extensive and successful experience at high-profile medical device companies
such as Guidant and Boston Scientific, Mr. Kameli brings not only a wealth of
experience in product development, but also a keen understanding of the
technical challenges and commercial opportunities in the high-growth
Neuromodulation industry", stated Mr. Benoit Huet, President and CEO of
Victhom. "Nader has the perfect mix of credentials and experience to drive the
development and to harness the great potential of our Neurobionix business
unit", Huet added. He also mentioned that the arrival of Mr. Kameli will allow
Mr. Stéphane Bédard to focus on the orthotic and prosthetic business unit of
    Mr. Kameli joins Victhom after eleven years of service at Guidant, now a
Boston Scientific company. At the Cardiac Rhythm Management unit of Boston
Scientific, he worked for six years managing product development, with a focus
on implantable devices, and the last four years as the Group Manager of
Business Development, identifying and utilizing external opportunities to
accelerate internal development and to complement internal know-how. In this
position, he managed the group involved in early- to late-stage engagements
with outside entities including mergers and acquisitions, joint ventures,
in-licensing, out-licensing and equity investments. Mr. Kameli has over
twenty-five years of experience in safety-critical product development and
covering product design, quality assurance, project management and business
development. He has worked in large companies such as United Technologies and
Boston Scientific as well as smaller companies such as Corometrics Medical
Systems and Better Packages. Mr. Kameli's educational background is in
electrical engineering and computer science, with emphasis in artificial
intelligence, neuroscience and business administration.

    About Victhom

    Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix business unit focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix business unit develops
biomechatronic products to support or replace peripheral limbs in what is
known as orthotics and prosthetics markets.
    Victhom's technologies and products are supported by a broad suite of
intellectual property, including a portfolio of 37 granted and 82 pending
patents filed in various countries and 13 registered trademarks, worldwide.
Victhom has established a comprehensive process to ensure the protection of
its intellectual property, pursuing filings for relevant discoveries and

For further information:

For further information: Victhom Human Bionics Inc.: Benoit Huet,
President and CEO, (418) 872-5665 ext. 103, Fax: (418) 872-6926,,; Media Relations: Frédéric Tremblay,
HKDP Communications and Public Affairs, (514) 395-0375, ext. 234,; Source: Victhom Human Bionics Inc.

Organization Profile

Victhom Human Bionics Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890